https://nighthawkrottweilers.com/

https://www.chance-encounter.org/

Business

Canopy Growth only confirmed what we have long suspected




<p class = "canvas-atom canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "In decades, the marijuana industry is going to be Depending on your preferred source, Wall Street companies are projecting anywhere from $ 50 billion in annual worldwide sales to as much as $ 200 billion in cannabis and cannabinoid sales per year around These figures in the sky have been a driving force for many years of power values. "data-reactid =" 1[ads1]6 "> In decades, the marijuana industry is a real giant. Depending on your preferred source, Wall Street companies are projecting anywhere from $ 50 billion in annual sales worldwide to as much as $ 200 billion in cannabis and cannabinoid sales per year around the world. These figures in the sky have been a driving force over the years.

<p class = "canvas-atom canvas text Mb (1.0em) Mb (0) – sm Mt 0.8em) – sm" type = "text" content = "However, the industry is not very close-view." Problems throughout North America have limited sales and seriously hampered the operating results of some of the industry's biggest names. Perhaps no more than the largest marijuana stock in the world at market value, Canopy Growth (NYSE: CGC). "data-reactid =" 17 "> But the near-term outlook for the industry is not so" buzzy. "A number of issues throughout North America have limited sales and severely hampered the operating performance of some of the industry's biggest names. stock in the world by market coverage, Canopy Growth (NYSE: CGC).

A jar packed with cannabis buds sitting on a spun pile of twenty dollar bills.

<h2 class Canopy Growth will not be profitable, provided it is not profitable , Canopy Growth cannot be profitable in fiscal 2020 "data-response time =" 29 "> As expected, Canopy Growth will not be profitable in fiscal 2020

<p class =" canvas-a empty canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm "type =" text "content =" Last week, Wall Street invested investment firm Jefferies, which offers the largest growth prospects for the global cannabis industry of 50 Billions of dollars in the sale of 2029, met with Canopy Growth's economy I was an officer, Mike Lee, who was appointed to his position less than two months ago. Although a number of topics were covered, as mentioned by Jefferies & # 39; tire analyst Andrew Bennett, an important part of the information that confirmed a suspicion that I and most of Wall Street have had for a while was discovered: Canopy Growth [n/a won It cannot be profitable in fiscal policy 2020 (Canopy's fiscal 2020 runs from April 1, 2019 to March 31, 2020). "data-reactid =" 30 "> Last year, Wall Street investment firm Jefferies, which offers the world's largest growth cannabis industry outlook of $ 50 billion by 2029, met Canopy Growth's chief financial officer, Mike Lee, who was appointed to his position less than two months ago, although a number of topics were covered, as mentioned by Jefferies, analyst Andrew Bennett, an important part of the information came to light that confirmed a suspicion that I and most of Wall Street have had one moment: Canopy Growth will not be profitable in fiscal policy 2020 (Canopy's fiscal 2020 runs from April 1, 2019-31 March, 2020).

<p class = "canvas-atom canvas text Mb (1.0em ) Mb (0) – sm Mt (0.8em) – sm "type =" text "content =" This should come as a little surprise to investors, with Wall Street's consensus revenue per share by 2020 for Canopy being settled negatively since February, and the company reported a negative net loss of 670 million Canadian dollars & nbsp; (about $ 513 million) in fiscal 2019. "Data Reaction =" 31 "> This should come as little surprise to investors. Wall Street's consensus revenue per share by 2020 for Canopy has been decisively negative since February, and the company reports a monstrous net loss of 670 million Canadian dollars (about $ 513 million) in fiscal 2019.

<p class = "canvas-textile-textile Mb (1.0em) Mb (0) – sm Mt (0.8em)" type = " text "content =" But Lee revealed some further details about Canopy who rightly should have Wall Street and investors hardened their expectations. In particular, Lee really got out of the idea that (formerly) management had posted where Canopy would turn $ 1 billion ($ 766 million) into fiscal 2020 revenue. For the forthcoming fiscal first quarter, at the end of June, Lee expects that The sales and gross margin – of which 19459026 was a weak 16% in the fourth quarter – would be more or less comparable to the sequential fourth quarter. This is surely jibed by the slow rise in sales of licensed cannabis stores in Canada, as well as Canopy's addiction to the revenue side of the revenue market. "Lee-Lee, however, revealed further details of Canopy who should rightly have withdrawn from the idea that (formerly) management had been out there as Canopy would turn $ 1 billion into $ 766 million in fiscal 2020 sales. The upcoming in the first quarter of last year, Lee expects sales and gross margin – which was a weak 16% in the fourth quarter – to be more or less comparable to the sequential fourth quarter, which is certainly jibed by the slow uptick in sales of licensed cannabis stores in Canada, as well as Canopy's dependence on the recreation side of the revenue market.

A Canadian flag with a red cannabis leaf instead of the maple leaf.

<h2 class = " canvas text text "Mb (1.0em) Mb 0) – sm Mt (0.8em) – sm" type = "text" content = " Three reasons Canopy Growth has no opportunity for a profit for 2020 "data-reactid =" 48 "> ] Three reasons Canopy Growth has no chance of a profit for 2020

If you are wondering why the biggest forecast of marijuana in the world is to be a laggard in the revenue department , it probably comes down to three factors.

<p class = "canvas-atom canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "First, point your finger at Health Canada. At the end of last year, Health Canada had over 800 licensing programs (cultivation, processing and sales) on the desktop to review. For context, Health Canada has approved fewer than 200 total licenses since 2013. Health Canada has recently implemented a solution for its seemingly insurmountable demand for licensing programs, but it will still take many quarters to work through. It is again Canopy, a company with over 4.8 million square meters of already licensed growing space, unable to move much of its product or increase sales in a fast "React =" 50 "> First, point your finger at Health Canada. At the end of last year, Health Canada had over 800 licensing programs (cultivation, processing and sales) on the desktop to review. For context, Health Canada has approved fewer than 200 total licenses since 2013. Health Canada has recently implemented a solution for its seemingly insurmountable backlog for licensing applications, but it will still take many quarters to work through. It is again Canopy, a company with more than 4.8 million square meters of already licensed growing rooms, unable to move much of its product or grow sales at a rapid pace.

<p class = "canvas-atom canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Second, Canopy's growth strategy hangs on expansion to significantly larger markets other than Canada, although Bruce Linton is no longer the company's visionary and co-director he orchestrated all Canopy & # 39; s major acquisitions and pushed it into new markets, monitoring Canopy & # 39; s victory when it became awarded a hopping process in New York State, and played a key role in securing the conditional rights agreement to acquire the US multistate dispensary operator Acreage Holdings for $ 3.4 billion in a cash and equity agreement with the unexpected fact that the US federal government must legalize marijuana, although Linton saw this expansion as necessary for Canopy to reach its long-term goals and corporate dominance, it has destroyed the company's bottom line. "Data-response time =" 51 "> Second, Canopy's growth strat egi on expansion to significantly larger markets than Canada Although Bruce Linton is no longer the company's visionary and co-responsible, he orchestrated all of Canopy & # 39; s major acquisitions and pushed into new markets. He oversaw Canopy's victory when it was awarded a hopping process in New York State, and played a key role in securing the subscription rights agreement to acquire the US multistate dispensary operator Acreage Holdings for $ 3.4 billion. in a cash and equity agreement, with the fact that the US federal government must legalize marijuana. Although Linton saw this expansion as necessary for Canopy to achieve its long-term goals and industry dominance, it's ravaged its bottom line.

A third and final reason for Canopy Growth has virtually allied no chance of being profitable in fiscal policy 2020 is the company's stock-based compensation. Linton angled to keep Canopy's ballooning workforce happy and loyal by setting them up with stock-based compensation as vest in the long run. Despite looking at his staff, former CEO Linton also ballooned Canopy's stock-based compensation cost in 2019. Investors are likely to expect a repeat in 2020.

Scissors cut a hundred dollar bill in half.

<h2 class = "canvas-atom texttext Mb (1.0em) Mb 0) – sm Mt (0.8em) – sm" type = "text" content = " Expect Canopy & # 39; s new CEO to be cost conscious above all else "data-reactid =" 64 "> Expect Canopy's new CEO to be cost conscious above all else

When the company announced Lintons resignation as CEO and board member on July 3, he also noted that the board was looking for a permanent CEO. This means that while Mark Zekulin was "promoted" to the CEO, he will also withdraw from his leadership role when a replacement is found (Zekulin was co-responsible with Linton).

Now, no one is absolutely sure who will lead Canopy Growth in the next phase of his maturation process. But one thing that is crystal clear is that the one who takes the reins is expected to keep a very tight bond on expenses. While it may be difficult to handle the equity-based compensation scheme while Linton was in charge of the company, Canopy's future CEO could certainly work to reduce operating costs, future stock-based prices, and withdrawals by just being more selective about which companies Canopy buys.

But no matter who Canopy Growth's board chooses to be the new CEO, it does not appear to be a path to profitability by 2020, nor is there any guarantee that the big money will begin flowing in by 2021, either .

<p class = "canvas-atom canvas text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = " More from The Motley Fool "data-response =" 69 "> More from The Motley Fool

<p class =" lerret- sm Mt (0.8em) – sm "type =" text "content =" Sean Williams [19659025] has no position in any of the aforementioned shares. Motley Fool has no position in any of the aforementioned shares. Motley Fool has a disclosure rules . "data-response time =" 78 "> Sean Williams has no position in any of the mentioned stocks. Motley Fool has no position in any of the aforementioned shares. Motley Fool has a disclosure policy .



Source link

Back to top button

mahjong slot

https://covecasualrestaurant.com/

sbobet

https://mascotasipasa.com/

https://americanturfgrass.com/

https://www.revivalpedia.com/

https://clubarribamidland.com/

https://fishkinggrill.com/